TRANSIT BIO
Food supplement declared in France, declaration No 2020-12-942, decision dated 17 December 2020
TRANSIT BIO is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 point in its composition requires a check (prohibited substance, dose or novel food). 2 rules of use apply to its ingredients (limits and warnings).
- Brand
- not provided
- Food business operator placing the product on the market
- BELLE & BIO (BELLE & BIO)
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Gélule
- Daily dose
- 4 gélules
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Utilisation prolongée
- Objectives stated by the manufacturer (these are not authorised claims)
- Transit
Declaration 305908, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- À vérifier
Contains a preparation of rhubarb (Rheum officinale) (racine). Preparations from this plant part containing hydroxyanthracene derivatives are under Union scrutiny (Annex III, Part C): a draft regulation sent to the Council on 15 July 2026 would prohibit them, with 12 months to sell through products already on the market. Their content is not declared.
Source: Regulation (EC) No 1925/2006, latest consolidated version, annexe III, partie C (règlement (UE) 2021/468) ; projet de la Commission D099926/3.
- Conditions légales
Rheum officinale Baill.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Conditions légales
Rheum palmatum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Althaea officinalis L. | Racine | Poudre (de plantes séchées ou broyées) | 500 mg |
| Angelica archangelica L. | Racine | Poudre (de plantes séchées ou broyées) | 200 mg |
| Rheum officinale Baill. | Racine | Extrait sec hydroalcoolique | 200 mg |
| Rheum palmatum L. | Racine | Extrait sec hydroalcoolique | 200 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Fibres solubles d'acacia | not declared |
Additives
Hydroxypropyl Méthyl Cellulose
Other ingredients
Gélule végétale
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
List recorded in 2020. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.